Abbvie Revenue 2025. Abbvie had revenue of $14.46b usd in the quarter ending september 30, 2024, with 3.83% growth. This brings the company's revenue in the last twelve months to $55.53b, up.
Abbvie had revenue of $14.46b in the quarter ending september 30, 2024, with 3.83% growth. And in 2025, abbvie expects rinvoq’s and skyrizi’s combined sales to reach $15 billion, fiercepharma reported.